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Abstract
Background: Amino acid sequence alignment of phage phiC31 integrase with the serine recombinases family revealed
highly conserved regions outside the catalytic domain. Until now, no system mutational or biochemical studies have been
carried out to assess the roles of these conserved residues in the recombinaton of phiC31 integrase.
Methodology/Principal Findings: To determine the functional roles of these conserved residues, a series of conserved
residues were targeted by site-directed mutagenesis. Out of the 17 mutants, 11 mutants showed impaired or no
recombination ability, as analyzed by recombination assay both in vivo and in vitro. Results of DNA binding activity assays
showed that mutants (R18A, I141A, L143A,E153A, I432A and V571A) exhibited a great decrease in DNA binding affinity, and
mutants (G182A/F183A, C374A, C376A/G377A, Y393A and V566A) had completely lost their ability to bind to the specific
target DNA attB as compared with wild-type protein. Further analysis of mutants (R18A, I141A, L143A and E153A) synapse
and cleavage showed that these mutants were blocked in recombination at the stage of strand cleavage.
Conclusions/Significance: This data reveals that some of the highly conserved residues both in the N-terminus and C-
terminus region of phiC31 integrase, play vital roles in the substrate binding and cleavage. The cysteine-rich motif and the
C-tail val-rich region of phiC31 integrase may represent the major DNA binding domains of phiC31 integrase.
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Introduction
The integrase from the bacteriophage phiC31 was first
described in 1991 as a 613 amino acid open reading frame
recombinase [1]. It can precisely mediates site-specific DNA
recombination between a bacterial attachment site (attB) and a
phage attachment site (attP) without requiring others cofactors,
resulting in integration when the two-att sites are present on two
different DNA molecules and deletion or inversion when the two-
att sites are on the same molecule [2,3]. After recombination
mediated integration, two hybrid attachment sites attR and attL are
generated, which are themselves no longer target sites for phiC31
integrase. Therefore, unlike tyrosine recombinases, such as Cre
and Flp [4], phiC31 integrase is a unidirectional integrase that
only supports integration, and the resulting integration is stable.
Presently, phiC31 integrase can perform recombination between
minimal 34-bp attB and 39-bp attP sites in human cells [5] and
mediates stable, site-specific integration of plasmids bearing attB
into attP sites randomly integrated into the genomes of cultured
human and mouse cells [6]. Furthermore, the phiC31 integrase
recognizes native sequences in human and mouse genomes that
possess partial sequence identity to attP, called pseudo attP sites,
and mediates the integration of plasmids bearing an attB site into
such pseudo attP sequences [6,7]. This ability of phiC31 integrase
to integrate into endogenous genomic sites has been used in gene
therapy applications[8,9,10,11] and engineering human embry-
onic stem cell lines and primordial germ cells [12,13]. In addition,
phiC31 integrase has been also used in the construction and
manipulation of multiple model organisms, such as Drosophila
[14,15,16,17], Xenopus [18], and mice [19,20]. These observations
demonstrate that the phiC31 integrase is a valuable tool for gene
therapy and genetic engineering.
The phiC31 integrase is a member of a serine-catalyzed
superfamily of site-specific recombinases [21]. It belongs to the
large serine integrase subfamily in which approximately 30 members
share a similar modular organization of an N-terminal catalytic
domain followed by an extended C-terminal region [21,22]. The
process of recombination by the large serine recombinases is thought
to have many steps. The first step is recognition and binding of the
substrates by the recombinase [23]. Protein–protein interactions
between the recombinase subunits then bring the two substrates
together in a synaptic complex [24]. Ghosh et al. showed that dimers
PLoS ONE | www.plosone.org 1 January 2010 | Volume 5 | Issue 1 | e8863of Bxb1 integrase bind the substrates attB and attP, which are then
probably brought together to form a synaptic tetramer [25]. DNA
cleavage occurs at a 2 bp crossover sequence site has been
demonstrated in both phiC31 and Bxb1 integrases [26,27,28].
Strand exchange is thought to occur by 180u rotation of two
recombinase subunits bound to half sites relative to the other two
subunits [29,30,31]. Rejoining of the products is dependent on the
complementarity of the DNA sequence at the staggered breaks; if
there is a mismatch at this sequence, joining of the products is
severely inhibited but iteration of strand exchange results in changes
in the topology of the substrates [27,32,33].
Site mutagenesis and deletion analysis are usually applied in the
study of protein functions. In three cases (phiC31 integrase, TnpX
from the Clostridium perfringens transposon Tn4451 and TndX from
the Clostridium difficile transposon Tn5397) site-directed mutagen-
esis of the proposed catalytic serine completely abolished their
recombination activity [2,34,35]. In an attempt to screen for the
phiC31 mutants that specifically recognized and integrated into
target sites more efficiently, the technique of DNA shuffling was
employed, and it had obtained many mutants, which with
increased integration efficiency in human cells [36,37]. Recently,
we have shown that DAXX, an important cellular protein in
human cells, can strongly bind to motif 451RFGK454 in the
phiC31 integrase, resulting in the decrease of the integration
efficiency of phiC31 integrase, indicating this region in the C-
terminal domain of phiC31 integrase played an important role in
protein-protein interactions [38]. Rowley et al. reported that a
motif in the C-terminal domain of phiC31 integrase controlled the
formation of the synaptic interface in both integration and
excision, possibly through a direct role in protein–protein
interactions [39]. They further demonstrated that substitutions
in amino acid V129 in the N-terminal domain can lead to defects
in synapsis and DNA cleavage, indicating that the N-terminal
domain also has an important role in synapsis [40].
Conserved residues, which are usually believed to be the
backbones of proteins, comprise pivotal structural and functional
information accumulated during the long history of evolutionary
screening. A sequence alignment of 30 serine recombinases
revealed conserved regions outside the catalytic domain [21].
Until now, no system mutational or biochemical studies have been
carried out to assess the roles of the conserved residues in the
recombinaton of phiC31 integrase. Using site-directed mutagen-
esis, these residues were individually mutated to alanine. Several in
vivo and in vitro assays were then used to investigate which of these
residues are important for the recombination process and,
furthermore, which steps of the recombination process are affected
by each mutation. Our results show that mutation of some of
highly conserved residues lead to a loss of biological activity and
that these defects are due to impaired DNA binding affinity or
specific target DNA cleavage, indicating that these conserved
residues located both in the N-terminus and C-terminus region of
phiC31 integrase are essential in DNA recombination. Multiple
regions were found to bind substrate DNA, among them the
cysteine-rich and the C-tail val-rich region may potentially be the
major DNA binding domains of the integrase.
Results
Comparison of the Primary Sequence of Members in the
Large Serine Integrase Family and Generation of PhiC31
Mutants
The phiC31 integrase has 613 residues and correspondingly a
molecular mass of 68 kDa. By aligning its amino acid sequence
with the serine recombinases family, we observed that it contains
approximately 62 highly conserved amino acids residues (Fig. 1),
and the cysteine-rich motif (aa372-403) followed by a leu/val/-rich
region (aa 447–571) in the C-terminal domain of integrase. To
determine the importance of conserved residues of phiC31
integrase during recombination, a series of 19 conserved residues
were targeted by site-directed mutagenesis, generating 17 mutants
(Table 1). To analyze the biochemical characterization of these
mutants, the wild-type and mutant phiC31 integrases were
expressed and purified as described in experimental procedures.
The final purity of fusion proteins was above 95%. The phiC31
integrase was pooled using salt gradient elution and analysed by
SDS-PAGE.
Mutations at Conserved Residuals both in the N-
Terminus and C-Terminus Affect the Recombinase
Activity
To test the recombination activity of mutant phiC31 integrases
in vivo, the wild-type or mutant plasmid containing an ampicillin
resistance gene, and the report plasmid pBCPB+ with attP and attB
sites in direct orientation flanking a lacZ gene on a chloramphen-
icol resistant, were co-transformed into an E. coli strain Top10.
The bacteria were then plated to form colonies on double
antibiotic selecting agar plates containing X-Gal. As mutant
recombinases still have their recombination ability, they will
catalyze integration of attP into the attB site, resulting in the
excision of the lacZ gene. This recombination event consequently
produces white colonies. When mutant enzymes have lost their
recombination ability, all colonies are blue. Our results showed
that out of the 17 mutants, 6 mutants (I288A, G296A, Q347A,
L350A, L468A and V495A) produced absolute white colonies as
wild-type integrase (Fig. 2A), and the recombination frequency
was nearly 100% as compared with wild-type protein (Table 2).
Two mutants (I141A and I432A) produced blue and white mixed
colonies (Fig. 2B), and the recombination frequency was 3.0%,
28.3% (Table 2), as compared with wild-type protein (P,0.05),
respectively. Meanwhile, 9 mutants (R18A, L143A, E153A,
G182A/F183A, C374A, C376A/G377A, Y393A, V566A and
V571A) produced absolute blue colonies (Fig. 2C), and the
recombination frequency was zero as compared with wild-type
protein (Table 2).
To further verify site-specific recombination at molecular level,
the white colonies were picked, and plasmid DNA was subjected to
PCR with specific primers that would amplify a 400-bp product
only from the recombinant (Fig. 2D). The sequence of this PCR
product contained the predicted chimeric attL site, comprising an
attP arm and attB arm around the core AA dinucleotides (Fig. 2E),
revealing that the recombination occurred between attP and attB
was mediated by the phiC31 integrase.
We carried out recombination assay of the purified mutant
phiC31 integrase in vitro. A linear substrate PB-L containing
correctly orientated attB and attP sites was employed for phiC31
integrase-mediated recombination reaction. When PB-L is cata-
lyzed by phiC31 integrase, it will result in the excision of the DNA
fragment between the attP and attB sites and be expected to give a
recircular pBCSK DNA molecular with attL (pBC-attL) and a
1.4 Kb linear DNA fragment with attR (attR-L) (Fig. 3A). Thus,
after recombination, besides a 4.9 kb band of linearized PB-L
(incomplete recombination by phiC31 integrase), four other bands
can be seen on agarose gel: a 1.4 kb band of linearized smaller
recombination product, and three bands of the larger circular
DNA molecule yielded by recombination (Fig. 3B). The linear attR
fragment product could be directly separated on an agarose gel
and stained with ethidium bromaide, and easily analyzed by
densitometric measurement. As shown in Figure 3, more than
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phiC31 integrase. Under the same conditions, 6 mutants (I288A,
G296A, Q347A, L350A, L468A and V495A) retained the
recombination activity nearly as high as wild-type phiC31
integrase as compared with wild-type protein (Fig. 3B), the
cleaved product of mutants I141A and I432A were observed to
show a weaker intensity of bands than that obtained with the wild-
type integrase (Fig. 3B), while no cleaved product was detected
from 9 mutants (R18A, L143A, E153A, G182A/F183A, C374A,
C376A/G377A, Y393A, V566A and V571A) (Fig. 3B). Each
mutant activity relative to that of the wild-type phiC31 integrase
was calculated (Table 2).
Reduced DNA Binding Affinity Correlates with Decrease
or Loss of the Recombination Activity
The recombination activity of the phiC31 integrase depends on
its ability to recognize and bind specific DNA sites. To analyze the
cause of decreased integrase activity of the mutants, the substrate
binding activity was measured by electrophoretic mobility shift assay
(EMSA). The characteristic of the complexes obtained by serial
Figure 1. Sequence alignment of eight members including phiC31 integrase within large serine integrase family. The conserved
residuals are shown in colour. Positions mutated in this study are indicated by asterisks. Sequence alignment was accomplished by using VNTI 9.0.
doi:10.1371/journal.pone.0008863.g001
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sites in bandshift experiments was considered at first. Adding
increasing amount of wild-type phiC31 integrase to the reaction
leads to the disappearance of the free-probe band, while three
protein-DNA complexes of retarded electrophoretic mobility can be
o b s e r v e d ,r e f e r r e da st oI ,I I ,a n dI I I ,a n dt h em a j o rs p e c i e so b t a i n e d
corresponding to the complex II (Fig. 4A and 4B). These results are
consistent with previous reports [26,28,41,42]. To check if the
observed shifted bands are specific, non-labeled attB probe was used
as cold competition oligonucleotide, and was added in excess. The
result showed that intense shifted bands of protein-DNA complexes
disappeared in the presence of the cold competitor (Fig. 5A and 5B).
Therefore, the shift observed was target specific.
To find out whether phiC31 mutants were still able to bind
substrates, we analyzed their ability to generate protein-DNA
complexes with attB (Fig. 5A). At the same concentration as wild-
type protein(400 nM), we observed that mutants R18A, I141A,
L143A, E153A, I432A and V571A were shown to have a great
decrease in DNA binding affinity approximately 1–6 fold as
compared with wild-type protein (P,0.05) (Table 2). Mutants
I141A, I432A and the wild-type protein were shown to lead to the
same three distinct complexes (I, II and III), while the band
patterns of R18A, L143A and E153A were observed to include the
formation of complexes (I and II) but with a weaker intensity of
complexes than that obtained with the wild-type integrase
(Fig. 5A). Especially, we observed that mutants G182A/F183A,
C374A, C376A/G377A, Y393A and V566A had completely lost
their ability to bind to the specific target DNA attB as compared
with wild-type protein, as no complexes were seen in the gel
retardation experiment (Fig. 5A).
In addition, we analyzed the ability of mutants to generate
protein-DNA complexes with specific target DNA attP. At the
same concentration of wild-type protein, we observed that mutants
R18A, I141A, L143A, E153A, C376A/G377A, Y393A, I432A,
V566A and V571A had an approximately 2–7 fold decrease in
DNA binding affinity as compared with wild-type protein
(P,0.05), and the band patterns of these mutants were different
(Fig. 5 B). For example, mutants R18A and L143A generated
protein -DNA complexes I, II and III, which was similar to that
of the wild-type protein with attP; mutant I141A generated protein
Table 1. Targeted residues and DNA sequence of mutagenic primers of phiC31 integrase.
Residue
a Conservation (% identity)
b Mutant(s) Complementary primers
Arg-18 100 R18A GTGCTTACGACGCTCAGTCGCGCGAG
CTCGCGCGACTGAGCGTCGTAAGCAC
Ile-141 80 I141A GTCATGGACCTGGCTCACCTGATTATG
CATAATCAGGTGAGCCAGGTCCATGAC
Leu143 60 L143A GACCTGATTCACGCGATTATGCGGCTCGACGCG
CGCGTCGAGCCGCATAATCGCGTGAATCAGGTC
Glu-153 80 E153A GCGTCGCACAAAGCATCTTCGCTGAAGTC
GACTTCAGCGAAGATGCTTTGTGCGACGC
Gly-182
Phe-183
80 G182A
F183A
GAAGGCGCCTTACGCCGCCGAGCTTGTTTC
GAAACAAGCTCGGCGGCGTAAGGCGCCTTC
Ile288 100 I288A CGTTATGCGAGCCCTTCGGGACCCG
CGGGTCCCGAAGGGCTCGCATAACG
Gly296 80 G296A CCGCGTATTGCGGCCTTCGCCGCTG
CAGCGGCGAAGGCCGCAATACGCGG
Gln-347 60 Q347A TATGAGCTTGCGGCGTGGTTGGACGGCA
TGCCGTCCAACCACGCCGCAAGCTCATA
Leu-350 60 L350A ATGAGCTTCAGGCGTGGGCGGACGGCAG
CTGCCGTCCGCCCACGCCTGAAGCTCAT
Cys-374 100 C374A CATGGACAAGCTGTACGCCGAGTGTGGCGCCGTC
GACGGCGCCACACTCGGCGTACAGCTTGTCCATG
Cys-376
Gly-377
100 C376A
G377A
AAGCTGTACTGCGAGGCTGCCGCCGTCATG
CATGACGGCGGCAGCCTCGCAGTACAGCTT
Tyr-393 100 Y393A ATCAAGGACTCTGCCCGCTGCCGTCGC
GCGACGGCAGCGGGCAGAGTCCTTGAT
Ile-432 60 I432A CATCTTCAACAAGGCCAGGCACGCCG
CGGCGTGCCTGGCCTTGTTGAAGATG
Leu-468 60 L468A CGGGCGAACGCTGTTGCGGAGCGCG
CGCGCTCCGCAACAGCGTTCGCCCG
Val-495 60 V495A GTACGACGGACCCGCTGGCAGGAAGCAC
GTGCTTCCTGCCAGCGGGTCCGTCGTAC
Val-566 80 V566A GTCGGGCTCTTCGCAGACAAGATCG
CGATCTTGTCTGCGAAGAGCCCGAC
Val-571 80 V571A GACAAGATCGTTGCCACGAAGTCGAC
GTCGACTTCGTGGCAACGATCTTGTC
aNumbers refer to positions in the wild-type 613 amino acid protein.
bRelation to a collection of 30 serine recombinases (http://www.blackwellscience.com/products/journals/suppmat/mole/mole2891/mmi2891sm.htm).
Mutated bases in the oligonucleotides are shown in bold.
doi:10.1371/journal.pone.0008863.t001
Mutational of Integrase
PLoS ONE | www.plosone.org 4 January 2010 | Volume 5 | Issue 1 | e8863-DNA complexes III; mutants E153A and I432A generated
protein-DNA complexes II; mutants Y393A,V566A and V571A
generated protein -DNA complexes I; mutants C376A/G377A
generated protein -DNA complexes I and II. Moreover, no
complexes were seen in the gel retardation experiment with DNA
attP for mutants G182A/F183A and C374A (Fig. 5B), indicating
G182A/F183A and C374A had completely lost their ability to
bind to the specific target DNA attP.
Several Mutants with Lower DNA Binding Affinity Can
Form a Synapsis but No Cleaved Intermediates
To investigate whether the mutants R18A, I141A, L143A,
E153A and I432A that show the lower affinity for the att sites also
affect the synapsis and cleavage steps, DNA synaptic complexes
and cleavage ability of the proteins were measured by EMSA. The
synaptic complexes and unbound substrates for the wild-type and
mutants phiC31 were separated on the same gel to compare their
synaptic complexes formation abilities at the same time. In binding
assays with wild-type integrase in the presence of a labeled attB
fragment and the 198 bp cold attP fragment, a major complex with
the same mobility as the designated synaptic complexes was
observed in addition to the shifted attB site (Fig. 6A). After
proteinase K treatment, these complexes disappeared and the
recombinant products attR and attL remains (Fig. 6A). Using the
same conditions as in the wild-type integrase, we observed the
band indicating the synaptic complexes in mutants R18A, I141A,
L143A and E153A, but no bands showing the recombinant
products, i.e. attR and attL, were detected (Fig. 6A and 6B).
Figure 2. Recombination assay of phiC31 mutants in E. coli. Each mutant plasmid and its report plasmid were co-transformed into Top10
bacteria, respectively. The bacteria were then plated to form colonies on double antibiotic selecting agar plates containing X-Gal. When mutant
recombinases still have their recombination ability, this recombination event consequently produces white colonies (A). When mutant integrase have
lost or reduced recombination ability, It is observed that mixture of white and blue colonies (B) or only blue coloneies (C) on the plates. To further
verify site-specific recombination at molecular level, the white colonies were picked, and plasmid DNA was subjected to PCR with specific primers
that would amplify a 400-bp product only from the recombinant. DNA from 5 white colonies was subjected to PCR with specific primers, and a 400-
bp product got amplified (D). The sequence of this PCR product contained the predicted chimeric attL site, comprising an attP arm (left) and attB arm
(right) around the core AA dinucleotides (gray ellipse).
doi:10.1371/journal.pone.0008863.g002
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the recombinant products attR and attL were detected, but the size
of attR and attL have slightly difference as compared with wild-type
protein (Fig. 6C).
Mutants Completely Losing Their DNA Binding Affinity
Have Structural Defects
To determine if the secondary structure of these proteins had
been significantly affected by the point mutations, we made an
analysis on the secondary structure of the wild-type integrase by
using fourier transform infrared (FT-IR) spectra. The result
showed that wild-type integrase was composed of 15.2% a-helix,
41.5% b-sheets and 43.3% unordered structures (Fig. 7). We
compared the circular dichroism (CD) spectra of the wild-type and
mutant proteins losing DNA binding activities. The secondary-
structure estimation, according to the CD spectra, revealed that
wild-type integrase was composed of 17.1% a-helix, 42.6% b-
sheets, 12.9% turns, and 27.4% random structures (Table 3),
which is consistent with that of FT-IR spectra. Comparison to
wild-type integrase CD spectra, mutants C374A and C376A/
G377A did not result in significant changes in the protein
secondary structure, however, mutants G182A/F183A, Y393A,
V566A and V571A had a significant change at b-sheets and turn,
respectively (Table 3 and Fig. 8), indicating that mutations of these
residues were likely to affect proper folding of the b-strands into a
hairpin structure.
Discussion
Conserved residues are thought of folding nucleus of functional
scaffolds in the history of protein evolution. They are also
important clues in finding domain structures and further in protein
engineering aimed to promote the applicable performance of
selected enzymes [43,44]. Sequence of phiC31 integrase can be
aligned with other members of the serine recombinase family and
it contains approximately 62 highly conserved amino acids
residues. Our purpose is to find out if these conserved residues
could give us more understanding of the domain architecture of
the phiC31 integrase, which is still not fully identified. Recently,
McEwan et al have found out that the large C terminal domain
was necessary for DNA binding and synapsis [45]. Thus, previous
research has shown evidence that both the N-terminus and C-
terminus are crucially important in the recombination [39,40].
However, we still cannot take a full picture of the process. So
locating the DNA binding domain or those key residuals in
substrate selection is currently a challenge in this field. Until now,
no system mutational or biochemical studies have been carried out
to assess the roles of the conserved residues in the integration
process. In this study, we first employed site-directed mutagenesis
to create 17 mutants, and verified the biological activity of these
mutants in vivo and in vitro. As a result, It was found that mutants
I288A, G296A, Q347A, L350A, L468A and V495A had a
recombination activity as wild-type integrase, showing that these
conserved residues were not important for recombination.
However, mutants R18A, L143A, E153A, G182A/F183A,
C374A, C376A/G377A, Y393A, V566A and V571A displayed
no detectable recombination activity, and mutants I141A and
I432A had a great decrease in activity, indicating that these
conserved residues were essential for recombination activity.
A defect in the recombination activity may result from the
inability of the mutant proteins to bind DNA substrates during
recombination. Results of DNA binding activity assays showed
that mutants (R18A, I141A, L143A, E153A, I432A and V571A)
exhibited a great decrease in DNA binding affinity approximately
1–6 fold, and mutants (G182A/F183A, C374A, C376A/G377A,
Y393A and V566A) had completely lost their ability to bind to the
specific target DNA attB as compared with wild-type protein.
These results indicated that these conserved residues play an
important role in the protein-DNA interactions, their mutations
had altered the ability of the mutant proteins to bind to the specific
DNA targets, leading to the loss or decrease of their biological
activity in vivo.
Sequence analysis showed that C-terminal domains of phiC31
integrase contained a cysteine-rich motif sharing a consensus
LXCXCG21YXCX42C (aa 372–403), which could be a zinc
finger-like domain, followed by a small leu/val-rich region (aa
447–571), which has a high probability of forming coiled-coil
structures [21,42,46]. Like the phiC31 integrase, TpnX belongs to
the large serine integrase subfamily, it also contained a putative
zinc binding motif (residues 318–360) and a small leucine- and
valine-rich region (aa 493–527). It has been shown that the
dimerization domain of TnpX was localized to a region in close
proximity to a putative C4 zinc finger domain and the leucine rich
region [41,42]. In addition, both of these motifs have been
implicated in other proteins as dimerization domains that facilitate
DNA binding [47]. Moreover, the C-terminal domains of Bxb1
and TnpX have been shown previously to be capable of binding
specifically to DNA [25,41,42]. Our results showed that five
mutations were located in the cysteine-rich motif and the Val-rich
region in the C-terminal domain of phiC31 integrase: C374A,
C376A/G377A and Y393A in cysteine-rich motif; V566A and
Table 2. Summary and comparison of the results for band
shift assays and the in vivo and in vitro recombination tests.
Mutants Recombination activity
DNA binding
affinities
c
In vivo (%)
a In vitro (%)
b attB
Wt phiC31 100 100 100
R18A 0 0 1662.1
I141A 3.060.2 2.660.1 5464.4
L143A 0 0 3864.0
E153A 0 0 4663.8
G182A/F183A 0 0 0
I288A 100 92.262.5 NA
G296A 100 96.163.1 NA
Q347A 100 98.662.5 NA
L350A 100 98.461.2 NA
C374A 0 0 0
C376A/G377A 0 0 0
Y393A 0 0 0
I432A 28.362.4 22.161.4 6165.5
L468A 100 96.263.2 NA
V495A 100 95.263.8 NA
V566A 0 0 0
V571A 0 0 15.661.7
aRecombination frequencies in vivo=white colonies/total colonies6100%.
bRecombination frequencies in vitro=band densities of mutant with attR-L/
band densities of wild-type integrase with attR-L6100%, assuming that 100%
of the wild-type integrase in the reaction was active.
cThe amount of free DNA substrate was plotted against concentrations of
integrase to calculate the apparent binding affinities, Kd. NA, not applicable.
The values reported are mean6SD of at least three curves.
doi:10.1371/journal.pone.0008863.t002
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PLoS ONE | www.plosone.org 6 January 2010 | Volume 5 | Issue 1 | e8863Figure 3. Recombination assay of the purified wild-type and mutant phiC31 integrases in vitro. (A) Schematic representation of
functional phiC31 integrase assay. The linear 4.9 kb DNA substrate (PB-L) containing correct attB and attP sites was treated with wild-type or mutants
phiC31 integrase, resulting in irreversibly produce a circular pBCSK molecule (or pBC-attL) and a 1.4 kb linear attR fragment (attR-L). (B) A 0.04 mM
linear DNA substrate (PB-L) was treated with a 0.1 mM purified wild-type or mutant phiC31 integrase in recombination buffer at 30uC for 30 min and
then stopped at 75uC for 10 min. The recombination reaction products were separated by electrophoresis on a 1% agarose gel. Arrows show the
positions of circular molecule (solid line arrows), and a linear attR fragment (dotted line arrows). Wt is wild-type.
doi:10.1371/journal.pone.0008863.g003
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five conserved residues located within these two region had almost
completely lost their ability to bind to the specific target DNA attB.
Therefore, we conclude that the cysteine-rich motif and the C-tail
Val-rich region of phiC31 integrase may represent the major DNA
binding domains of the phiC31 integrase.
We have previously demonstrated that cellular protein DAXX
can strongly bind to motif 451RFGK454, which located within the
leucine rich region in the C-terminal domain of phiC31 integrase,
indicating this region played an important role in protein-protein
interactions [38]. Rowley et al. reported that mutations in the C-
terminal coiled-coil region cause hyperactivity, i.e., integrase is
able to mediate both attB x attP and attL x attR synapsis and
recombination, it indicats that this region has a direct role in
protein-protein interactions in synapsis [39]. Together these data
suggests that conserved residues located within a cysteine-rich
motif and the leucine-and valine-rich region in the C-terminal
domain of phiC31 integrase play an important role in both the
protein-DNA and protein-protein interactions. However, further
research is needed to identify if mutation of these conserved
residues located within a cysteine-rich motif and the leucine-and
valine-rich region in the C-terminal domain of phiC31 integrase
will affect multimerization characteristic of these proteins.
What is more, the N-terminal conserved residuals are also
involved in the DNA binding, such as, mutation of conserved
residuals (G182A/F183) located within N-terminal domains of
phiC31 integrase had completely lost their ability to bind to the
specific target DNA attB. Therefore, we suggest that another
putative DNA binding region also lies N-terminal of phiC31
integrase. Previous evidence demonstrated that there were
multiple DNA binding regions located in N-terminus and C-
terminus of other members of the large serine integrase family. For
example, recent work on the serine integrase of mycobacterioph-
age Bxb1 suggests that at least two protein regions are required for
efficient binding to its att sites [25]. The large serine recombinase,
TnpX, have been also shown to have three DNA binding regions
(aa 533–597, aa 243–261 and aa 598–707) [41,42,46].
Based on the results of mutants synapse and cleavage analysis,
we have found more functional conserved residuals in the N-
terminus of phiC31 integrase. Mutants R18A, I141A, L143A and
E153A with lower affinities for the att sites can form a synapse with
attB- attP, but the next step in recombination, i.e. cleavage and
strand exchange is severely blocked. Similarly, in a previous study
in which the affinity of the mutant S12A for wild-type attP and attB
sites were assayed and found to be approximately 2-fold lower
than the wild-type phiC31 integrase, and mutant S12A was able to
form a synapse but unable to form the cleaved intermediates [28].
Rowley et al also showed that mutation of amino acid V129 in the
N-terminal domain of phiC31 integrase could lead to defects in
cleavage [40]. Together these data suggests that some conserved
amino acids in the N-terminus of phiC31 integrase would also play
such an important role in DNA cleavage.
Additionally, mutants I432A were shown to have a decrease in
DNA binding affinity approximately 40% as compared with wild-
type protein. This correlates well with our in vivo assay results, i.e.
the recombination efficiency is proposed to be mainly affected by
the decrease of binding affinity. So we further tested whether these
mutants might be also defective in the step that follows DNA
binding, i.e., synapsis and DNA cleavage. Our results showed that
mutants I432A can form both the synaptic complexes and the
cleaved intermediates, but size of attR and attL have slightly
difference as compared with wild-type protein. The reason needs
further studied.
In summary, our results show that mutation of some highly
conserved residues lead to the loss of recombination activity and
that these defects are due to impaired DNA binding affinity or
affect specific target DNA cleavage, indicating that these
conserved residues both in the N-terminus and C-terminus region
of phiC31 integrase are essential in DNA recombination. We
conclude that putative DNA binding regions lie in both the N-
terminus and C-terminus of phiC31 integrase; especially, the
cysteine-rich motif and the C-tail Val-rich region of phiC31
integrase may represent the major DNA binding domains of
phiC31 integrase. Our work has also given clues for the further
study of the N-terminus and C-terminus truncate mutation of
phiC31 integrase to verify their roles in the DNA binding
specifically and synaptic complexes formation. It offers useful
information to those attempting to modify phiC31 integrase for
more effective and more convenient applications in DNA
manipulations.
Figure 4. Assay of DNA binding activity of wild-type phi C31 integrase. A fixed amount (16 fmol) of a 41 bp biotin -labeled attB fragment
(A) or a 50 bp biotin -labeled attP fragment(B) was incubated with varying amounts of purified wild -type phi C31 in binding buffer at 30uC for
30 min. Reactions were analyzed by polyacrylamide gel electrophoresis (5% polyacrylamide, 1x Tris-borate-EDTA). Arrows show the positions of free
probe (F) and the DNA binding complexes (I, II and III).
doi:10.1371/journal.pone.0008863.g004
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Plasmid, Bacterial Strains and Culture Media
The plasmid pCMVInt, which expresses phiC31 integrase in
mammalian cells under control of the cytomegalovirus (CMV)
immediate-early promoter, and the pBCPB+ plasmid, which
carries the phiC31 recognition site attP and attB in direct
orientation flanking a lacZ gene on a chloramphenicol resistant
ColE1 derivative, were a kind gift from Dr. M.P. Calos. Restriction
endonucleases, pyrobest polymerase and T4 DNA ligase, were
purchased from TaRaKa (Dalian, China). The Ni-NTA agarose
column, the expression vector pET22b+, and its host Escherichia coli
BL21 (DE3) were obtained from Novagen (Darmstadt, Germany).
Isopropyl-1-thio-b-D-galactopyranoside (IPTG), sodium dodecyl
sulfate (SDS), dithiothreitol (DTT) and glycine were purchased
from Sigma (St. Louis, USA). All reagents were of biotechnological
grade.
Recombinant DNA and PhiC31 Mutagenesis
To generate an expression vector for wild-type phiC31 integrase
with C-terminal His-tagged, a 1.8 kb fragment was amplified from
pCMVint by PCR with primers 59- ATACATATGACA-
CAAGGGGTTGTGAC-39 and 59-GTGCTCGAGGC CGCT-
ACGTCTTCCGTG -39. The amplified product, was digested
with Nde1 and Xho1, and cloned into plasmid pET22b(+) digested
with the same enzymes. The ligation mixture was used to
transform Escherichia coli strain and selected on LB-Agar plates
containing ampicillin (100 mg/ml). The recombinant were ana-
lyzed by restriction digestion and confirmed by automated DNA
sequencing (Invitrogen, shanghai, China), and named as pET22b-
C31.
PhiC31 mutants obtained by using the QuikChange site-
directed mutagenesis kit (Stratagene) according to the supplier’s
instructions, with plasmid pET22b-C31 as the template. For each
point mutation, two complementary primers having mutated
positions were used (Table 1). After initial denaturation at 95uC for
0.5 min, the cycling parameters were 0.5 min at 95uC followed by
1.0 min at 55uC and 12 min at 68uC (12 cycles). The reaction
mixtures were placed on ice for 2 min, and then the parental,
supercoiled double-stranded DNA was digested with 0.5 mlo fDpnI
at 37uC for 1 h before being transformed into competent E. coli
XL1 Blue cells. Mutations were verified by DNA sequencing, and
named as pET22b-MC31.
Protein Expression and Purification
The wild-type and mutant phiC31integrases expression plas-
mids were transformed into Escherichia coli strain BL21 (DE3),
respectively. For expression, a single colony was used for
inoculation in LB medium contained 50 mg/mL ampicillin. When
the OD600 reached 0.8, the cells were induced by 0.1 mM IPTG
for 30 h at 18uC with shaking. Then the cells were harvested and
resuspended in cold lysis buffer H (20 mM Tris-Cl, pH 8,
500 mM NaCl, 20 mM imidazole). The lysate was disrupted by
gentle sonication and the suspension was centrifuged for 40 min at
12,000 g. The lysate supernatant was directly loaded onto 5 ml
Ni-NTA agarose column that was pre-equilibrated in lysis buffer
H. After extensive washing in the same buffer, the column was
eluted with lysis buffer H containing 500 mM imidazole
concentrations. After SDS–PAGE, the pure fractions containing
the recombinant protein were pooled and concentrated to 20 mg/
ml in sample buffer (5 mM Tris-Cl, pH 8, 1 M NaCl) by
ultrafiltration, then added 10% glycerol and stored at 270uC.
Protein concentrations were determined by the Bradford assay.
Figure 5. Assay of DNA binding activity of mutant phi C31
integrases. A fixed amount (16 fmol) of a 41 bp biotin -labeled attB
fragment (A) or a 50 bp biotin -labeled attP fragment (B) was incubated
with a similar amount of purified wild -type and mutant phi C31 in
binding buffer at 30uC for 30 min. Results were analyzed by
polyacrylamide gel electrophoresis (5% polyacrylamide, 1x Tris-borate-
EDTA). Arrows show the positions of free probe (F) and the DNA
binding complexes (I, II and III).
doi:10.1371/journal.pone.0008863.g005
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PLoS ONE | www.plosone.org 9 January 2010 | Volume 5 | Issue 1 | e8863Figure 6. DNA synapsis and cleavage assays with wild-type and mutant integrases. Labelled attB was incubated with wild-type or mutant
integrases (Panel A:R18A, I141A; Panel B:L143A, E153A; Panel C:I432A) in the presence of no cold attP, 198 bp cold attP in binding buffer and then
untreated or treated with proteinase K. Reactions were analyzed by polyacrylamide gel electrophoresis (5% polyacrylamide, 1x Tris-borate-EDTA). The
complexes observed are integrases (Int) bound to attB or synaptic complexes (SC). The recombinant products attL and attR are also indicated.
doi:10.1371/journal.pone.0008863.g006
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Recombination assays in vitro were performed as described
previously [28], with modifications. Briefly, the substrate for
determining phiC31 activity was a 4.9 Kb linear DNA pBL from
plasmid pBCPB+ digested with HindIII and EcoRV. When phiC31-
mediated intramolecular recombination occurs between the attP and
attB sites flanking an origin of replication and an antibiotic
(chloramphenicol) resistance gene, the resulting products are two
molecules. One product is a supercoiled pBCSK plasmid (pBC-attL)
carrying attL, and the other is a single linear fragment attR-L
carrying attR. All recombination reactions were in a 20 ml reaction
volume containing enzyme reaction buffer (50 mM glycine-NaOH,
PH 8.5, 100 mM KCl, 10 mM DTT, 0.01% bovine serum
albumin), 0.04 mM linear DNA substrates, and 0.1 mMp h i C 3 1
integrase. Reactions were performed at 30uCf o r3 0m i na n dt h e n
stopped at 75uC for 10 min. Subsequently, reaction products were
directly separated on a 1% agarose gel and stained with ethidium
bromaide (1 mg/ml) for 20 min. A 1.4 Kb linear attR fragments
band densities were analyzed by using a UVP-GDS8000 gel analysis
system (Ultra-Violet Products Ltd, Cambridge, UK). To measure
the residual activities more precisely, the reactions were performed
with higher concentraions of the proteins,and the activities relative
to that of wild-type phiC31 integrase were calculated.
Figure 7. FT-IR spectra of the phiC31 integrase in heavy water. The second derivative of the infrared spectrum (A) and the absorption profile
of the amide I’ band (B).
doi:10.1371/journal.pone.0008863.g007
Table 3. Secondary structure estimation from CD spectra of
wild-type and mutant phiC31 integrases.
a-helicity (%) b-sheet (%) Turn (%) Random (%)
Wt phiC31 17.10 42.60 12.90 27.40
G182A/F183A 17.50 22.40 27.10 33.00
C374A 18.60 39.10 13.10 29.20
C376A/G377A 18.20 35.20 17.70 28.90
Y393A 17.70 22.30 27.20 32.90
V566A 23.80 24.90 22.30 29.00
V571A 23.90 26.90 16.40 32.80
doi:10.1371/journal.pone.0008863.t003
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Recombination assays in vivo were performed as described
previously [38]. A 200 ng sample of pET22b-MC31 plasmid and a
100 ng sample of the pBCPB+ plasmid were co-transformed into
Top10 bacteria, which were allowed to recover for 1 h, then
spread on agar plates containing 25 mg/ml chloramphenicol,
50 mg/ml ampicillin, and 50 mg/ml 5-bromo-4-chloro-3-indolyl b-
Dgalactoside (X-Gal), and grown at 37uC. If an intramolecular
integration event occurs, the lacZ gene located between the attB
and attP sites will be excised, and a resulting colony will be white.
The frequency of intramolecular recombination was calculated as
the number of white colonies divided by the total number of
colonies and multiplying by 100. Each frequency is derived from at
least three independent experiments.
DNA isolated by plasmid extraction from five different white
colonies was subjected to sequence analysis for further verifying
the recombination. The primers attB-F (59-GGCGAGAAAG-
GAAGGGAAGA-39) and attP-R (59- ATTAACCCTCAC-
TAAAGGGA-39) were used to specifically amplify the wild type
attL junction in integrase-reacted pBCPB.
DNA Binding Assays
DNA fragments containing the attachment sites attB and attP were
prepared for use as substrates in EMSA [28,42]. Groth et al
demonstrated that these att sites are functional with the minimal
lengths of 34 bp for attB and 39 bp for attP [22]. In our experiments,
the attB and attP f r a g m e n t su s e da ss u b s t r a t e sa r ea4 1b pa n da
50 bp in length, respectively. Linear substrates containing the attB or
attP sequence were synthesized and labeled by Invitrogen Company,
Shanghai, China. The sequences of biotin- DNA probes that were
double-strand end-labeled were attB (59- CGGGTGCCAGGGC-
GTGCCCTTGGGCTCCCCGGGCGCGTACT-39 and 59-A G -
TACGCGCCCGGGGAGCCCAAGGGCACGCCCTGGCACC-
CG-39)a n dattP(59-GTAGTGCCCCAACTGGGGTAACCTTT-
GAGTTCTCTCAGTTGGGGGCGTAG-39 and 59-CTACGC-
CCCCAACTGAGAGAACTCAAAGGTTACCCCAGTTGGG-
GCACTAC-39). PhiC31 DNA binding activity was detected by
using a LightShift Chemiluminescent EMSA kit (Pierce, USA)
according to the manufacturer’s instructions. Briefly, the wild type
and mutant protein were mixed with binding buffer (50 ng/ml
Poly, 0.05% NP-40, 50 mmol/L KCl, 5 mmol/L MgCl2 and
10 mmol/L ethylenediamine tetraacetic acid) in a total volume of
20 mL containing 0.4 ng the biotin- attB DNA probes or biotin- attP
DNA probes, respectively. For competition experiments, usually
100-fold excess unlabeled competitor DNA attB/attP was added to
the reaction mixture on ice for 10 min prior to the addition of the
labeled probe. The mixtures were incubated for 30 min at room
temperature before the addition of 3 mLo f5 6loading buffer.
Samples were loaded onto a native 8% polyacrylamide gel, and
were electrophoresed at 100 V until the bromophenol blue dye had
migrated approximately two-thirds to three-quarters of the length of
the gel, and then the binding reactions were electro blotted onto
nylon membrane at 380 mA (,100 V) for 1 h. The membrane was
cross-linked for 2 min at a distance of approximately 0.5 cm from
an ultraviolet lamp equipped with 254 nm bulbs, and biotin-labeled
DNA was visualized by using enhanced chemoluminescence. The
images were developed on X-ray film and the band densities were
analyzed by using a UVP-GDS8000 gel analysis system (Ultra-
Violet Products Ltd, Cambridge, UK). The amount of free DNA
substrate was plotted against concentrations of integrase to calculate
the apparent binding affinities, Kd.
DNA Synapsis and Cleavage Assays
DNA synapsis and cleavage assays were performed as described
previously [28]. For synapsis assays, the unlabelled ‘partner’
fragments attP (198 bp) prepared by PCR amplification from
pTA-attP with primers attP-F(59- ACTGACGGACACACC-
GAAGC-39) and attP-R (59- TCGTAAGCACCCGCGTACG-
TGTC-39). 0. 4 ng labelled probe attB (41 bp) was mixed with
12 ng of cold partner fragment and 0.8 mg integrase in 20 mL
binding buffer. Reactions were incubated at 30uC for 2 h prior to
electrophoresis. To detect the cleavage of the DNA fragments by
integrase, samples required proteinase treatment. Briefly, samples
were first heat inactivated by incubation at 72uC for 10 min and
then treated proteinase K (1 mg in 5 mM EDTA, 0.5% SDS;
incubated at 50uC for 30 min). Finally, samples were incubated
at 72uC for an additional 10 min to inactivate the proteinase
prior to polyacrylamide gel electrophoresis (5% polyacrylamide,
1x Tris-borate-EDTA).
FT-IR Spectroscopy and Circular Dichroism Spectroscopy
FT-IR measurements of the phiC31 integrase in heavy water
were performed as described previously [48]. Circular dichroism
measurements were performed on a Jasco 715 spectropolarimeter
(Jasco, Tokyo, Japan) using a quartz cuvette with 0.1 cm path
length over a wavelength range of 190–250 nm at 25uC. Protein
was dissolved in 0.15 M sodium chloride, pH 7.0. The CD data
were collected every 0.2 nm and were the average of four scans.
The Results were expressed in units of molar ellipticity per residue
(deg cm2 dmol-1) and plotted versus the wavelength. The
bandwidth was set at 1.0 nm and the sensitivity at 25 mdeg.
The response time was 0.5 s. In all cases, baseline scans of control
buffers were subtracted from the experimental readings. CD data
were processed by Jasco secondary structure estimation software.
Computer Analysis
For sequence analysis we used the Align X in VNTI 9.0
software package. Protein secondary structure predictions were
Figure 8. CD spectra of wild-type and mutant phiC31 proteins.
Far UV spectra from 190 to 250 nm of wild-type phiC31 and mutants
G182A/F183A, C374A, C376A/G377A, Y393A, V566A and V571A were
shown, at 25uC using a 0.02-cm quartz cell. Protein was dissolved in
0.15 M sodium chloride, pH 7; Other conditions were described in
Experimental Procedures. Wt is wild-type.
doi:10.1371/journal.pone.0008863.g008
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,phiwww/prof/) and Jpred 3 (http://www.compbio.dundee.ac.
uk/,www-jpred/).
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